Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Merck KGaA

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.

Merck KGaA

Roche reports positive results for drug for relapsing forms of MS

Roche reports positive results for drug for relapsing forms of MS

Last month, Merck KGaA’s BTK inhibitor evobrutinib was put on partial clinical hold by the US Food and Drug Administration (FDA) following two reports of drug-induced liver injury.

Merck KGaA’s MS drug put on partial clinical hold by FDA

Merck KGaA’s MS drug put on partial clinical hold by FDA Merck KGaA has said that the US Food and Drug Administration (FDA) has placed a partial clinical hold on new patients receiving its multiple sclerosis (MS) drug candidate evobrutinib. ... Merck is working closely with the FDA to establish the best path

Merck and Proxygen partner in deal worth up to $2.5bn

Merck and Proxygen partner in deal worth up to $2.5bn Merck KGaA then teamed up with the company just over a year later in June 2022. ... identifying novel molecular glue degraders with Merck’s world class research and development capabilities.

Merck KGaA and Aqilion AB partner in potential €960m deal

Merck KGaA and Aqilion AB partner in potential €960m deal Merck KGaA and Aqilion AB have entered into an exclusive licence and strategic research partnership to advance small molecule inhibitors of the TAK1 protein, thought to play a central role in ... Aqilion will be responsible for the design and synthesis

Merck KGaA and Mersana partner in potential $830m deal

Merck KGaA and Mersana partner in potential $830m deal The collaboration will see Mersana develop novel ADC product candidates for up to two targets, utilising its platform to combine Merck KGaA's proprietary antibodies. ... Pre-clinical activities will be split between the two companies, with Merck KGaA

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Because health means everything...

Latest intelligence

Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Tuberculosis – why it remains a major global public health challenge
Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
Whitepaper: Closing the gap with compelling healthcare communications
Want to learn how to close the distance between a person’s current health and their healthiest possible self?...